US Broker Ratings

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 144% Potential Upside in a Pioneering Biotech Firm

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a name that investors in the biotechnology sector should keep an eye on, especially those interested in the cutting-edge field..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Biotech Gem with 422.95% Upside Potential

Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands as a compelling opportunity in the biotechnology sector, offering a fascinating proposition for investors who are keen on the healthcare..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a Potential 37% Upside in the Medical Device Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI) stands as a notable player within the healthcare sector, specifically focusing on the medical devices industry in the United States...

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 55% Potential Upside Amidst Robust Revenue Growth

AngioDynamics, Inc. (ANGO), a prominent player in the medical technology landscape, is capturing investor attention with a robust revenue growth of 12.90% and an enticing potential..

Autolus Therapeutics (AUTL) Stock Analysis: Exploring a Potential 497% Upside in Biotech Innovation

For investors with a keen eye on the biotechnology sector, Autolus Therapeutics plc (NASDAQ: AUTL) presents an intriguing opportunity. With a potential upside of nearly 497.65%,..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Understanding the 154.94% Potential Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a prominent player in the biotechnology space, has been capturing investor attention with its innovative approach to treating serious retinal diseases...

Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Innovator with a 370% Potential Upside

Humacyte, Inc. (NASDAQ: HUMA) is making waves in the biotechnology sector with its revolutionary approach to developing off-the-shelf, implantable, and bioengineered human tissues. With a market..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring an 89% Potential Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the healthcare sector, specializes in regenerative medicine, offering advanced wound care, surgical, and sports medicine solutions. Despite..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 50% Upside Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to cancer treatment. With a market..

GH Research PLC (GHRS) Stock Analysis: Unpacking the Potential 146% Upside in Healthcare Biotech

As investors navigate the intricate world of biotechnology stocks, GH Research PLC (NASDAQ: GHRS) stands out as a company with significant growth potential. Based in Dublin,..

Myriad Genetics, Inc. (MYGN) Stock Report: Analyzing the Challenges and Opportunities in Diagnostics

Myriad Genetics, Inc. (NASDAQ: MYGN) stands at an intriguing crossroads in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

Butterfly Network, Inc. (BFLY) Investor Outlook: Analyzing the 61.56% Potential Upside

Butterfly Network, Inc. (NYSE: BFLY), a key player in the healthcare sector specializing in medical devices, has recently captured the attention of investors with its innovative..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Significant 122% Upside Potential with Strong Buy Ratings

Oruka Therapeutics, Inc. (NASDAQ: ORKA) has been capturing the attention of investors with its promising pipeline of monoclonal antibody therapeutics targeting inflammatory and immunology conditions such..

Geron Corporation (GERN) Stock Analysis: Assessing a 162.68% Potential Upside in the Biotechnology Sector

For investors keeping a keen eye on the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents an intriguing opportunity. With a current market capitalization of $880.46 million,..

Orthofix Medical Inc. (OFIX) Stock Analysis: Evaluating a 59.98% Potential Upside Amidst Medical Device Innovation

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, operates within the specialized niche of medical devices. With a market capitalization of $561.21..

Cel-Sci Corporation (CVM) Stock Analysis: A Biotech Gamble with Over 1,600% Potential Upside

Cel-Sci Corporation (NYSE American: CVM) has emerged as an intriguing player in the biotechnology sector, drawing attention from investors with its significant potential upside. With a..

Claritev Corporation (CTEV) Stock Analysis: Exploring a 51.91% Potential Upside in Healthcare Innovation

Claritev Corporation (NASDAQ: CTEV) is capturing investor attention with its substantial potential upside of 51.91%, as reflected in recent analyst ratings. Operating within the healthcare sector,..

Beta Bionics, Inc. (BBNX) Stock Analysis: High Growth Potential with 54.40% Revenue Surge

Beta Bionics, Inc. (NASDAQ: BBNX), a trailblazing healthcare company in the medical devices sector, is making waves with its groundbreaking solutions aimed at improving the lives..

Semler Scientific, Inc. (SMLR) Stock Analysis: Unveiling a Potential 140% Upside for Savvy Investors

Semler Scientific, Inc. (NASDAQ: SMLR), a key player in the healthcare sector focused on medical devices, presents a tantalizing prospect for investors seeking substantial returns. With..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech with 259.91% Potential Upside

MBX Biosciences, Inc. (NASDAQ: MBX), a biopharmaceutical company headquartered in Carmel, Indiana, is gaining significant attention from investors, thanks to its promising pipeline of peptide therapies..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds